Natixis Advisors’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-89,624
Closed -$1.58M 1514
2022
Q4
$1.58M Buy
89,624
+310
+0.3% +$5.19K 0.01% 1011
2022
Q3
$1.36M Buy
89,314
+14,546
+19% +$235K 0.01% 1015
2022
Q2
$1.11M Sell
74,768
-11,710
-14% -$219K ﹤0.01% 1091
2022
Q1
$1.95M Buy
86,478
+16,642
+24% +$337K 0.01% 968
2021
Q4
$1.29M Buy
69,836
+6,586
+10% +$105K ﹤0.01% 1070
2021
Q3
$845K Sell
63,250
-5,525
-8% -$89.2K ﹤0.01% 1118
2021
Q2
$1.27M Buy
+68,775
New +$1.16M 0.01% 1040

Other funds holding MDRX

Natixis Advisors's MDRX Position: Q1 2023 in Review

Natixis Advisors sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2023, closing a stake of 89,624 shares — an estimated $1.58M sold.

Natixis Advisors first reported a position in MDRX in Q2 2021 and held it in 7 quarters. The position peaked at $1.95M in Q1 2022. 242 funds tracked by Wall St. Rank hold MDRX as of Q1 2023.

  • Natixis Advisors reported no remaining Veradigm Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Natixis Advisors sold 89,624 Veradigm Inc. Common Stock shares in Q1 2023, an estimated $1.58M.
  • Natixis Advisors first reported a position in Veradigm Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Natixis Advisors's Veradigm Inc. Common Stock position peaked at $1.95M in Q1 2022.
  • 242 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2023.

Based on Natixis Advisors's 13F filing for Q1 2023, filed 11 May 2023.